Cervical cancer immunotherapy: facts and hopes
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …
Prophylactic and therapeutic HPV vaccines: current scenario and perspectives
Y Mo, J Ma, H Zhang, J Shen, J Chen… - Frontiers in cellular …, 2022 - frontiersin.org
Persistent human papillomavirus (HPV) infection is recognized as the main cause of cervical
cancer and other malignant cancers. Although early detection and treatment can be …
cancer and other malignant cancers. Although early detection and treatment can be …
Immunologic treatments for precancerous lesions and uterine cervical cancer
P Vici, L Mariani, L Pizzuti, D Sergi, L Di Lauro… - Journal of Experimental …, 2014 - Springer
Abstract Development of HPV-associated cancers not only depends on efficient negative
regulation of cell cycle control that supports the accumulation of genetic damage, but also …
regulation of cell cycle control that supports the accumulation of genetic damage, but also …
[PDF][PDF] Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
Cervical cancer is the fourth most lethal women's cancer worldwide. Current treatments
against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic …
against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic …
Current and future direction in treatment of HPV-related cervical disease
N Khairkhah, A Bolhassani, R Najafipour - Journal of Molecular Medicine, 2022 - Springer
Human papillomavirus (HPV) is the most common sexually transmitted virus in the world.
About 70% of cervical cancers are caused by the most oncogenic HPV genotypes of 16 and …
About 70% of cervical cancers are caused by the most oncogenic HPV genotypes of 16 and …
Antigen‐specific immunotherapy of cervical and ovarian cancer
We contrast the efforts to treat ovarian cancer and cervical cancer through vaccination
because of their different pathobiology. A plethora of approaches have been developed for …
because of their different pathobiology. A plethora of approaches have been developed for …
Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines
M Oladejo, W Paulishak, L Wood - Seminars in Cancer Biology, 2023 - Elsevier
Cancer vaccines and immune checkpoint inhibitors (ICIs) function at different stages of the
cancer immune cycle due to their distinct mechanisms of action. Therapeutic cancer …
cancer immune cycle due to their distinct mechanisms of action. Therapeutic cancer …
Current state in the development of candidate therapeutic HPV vaccines
A Yang, J Jeang, K Cheng, T Cheng… - Expert review of …, 2016 - Taylor & Francis
The identification of human papillomavirus (HPV) as an etiological factor for HPV-associated
malignancies creates the opportunity to control these cancers through vaccination …
malignancies creates the opportunity to control these cancers through vaccination …
Therapeutic human papillomavirus vaccines: current clinical trials and future directions
Background: Cervical cancer is the second largest cause of cancer deaths in women
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases
Carcinomas of the anogenital tract, in particular cervical cancer, remains one of the most
common cancers in women, and represent the most frequent gynecological malignancies …
common cancers in women, and represent the most frequent gynecological malignancies …